GLP-1 medications safe to continue before surgery in patients with diabetes and obesity owenhaskins Jun 5, 2024 3 min read There are only mild differences in gastric emptying among patients taking glucagon-like peptide-1 (GLP-1) receptor agonist medications for type 2 diabetes and weight loss, according to a meta-analysis and review of 15 randomised studies by researchers from Brigham and Womens Hospital
For Clinicians Fellow practitioner: you are standing at the frontier of metabolic medicine
Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, Simpson JA, Drucker DJ
New Monthly GLP-1 Injectable MariTide Results in 20% Weight LossWith No Plateau While the drug from Amgen is still in development, early trials show promising results In the same way weight varies from person to person, so do the best weight loss strategies
After first use The Ozempic injection pen contains multiple doses